Covid-19 and Rehabilitation Outcomes: A Case-Control Study

被引:1
|
作者
Petzold, Stefanie [1 ]
Carney, Roisin [2 ]
Kool, JanPieter [3 ]
Bachmann, Stefan [4 ,5 ]
机构
[1] Kliniken Valens Rehazentrum Walenstadtberg, Klin Muskuloskelettale & Internist Rehabiltat, Walenstadt, Switzerland
[2] Kliniken Valens Rehazentrum Walenstadtberg, Physiotherapien, Walenstadt, Switzerland
[3] Forschungsabteilung, Kliniken Valens Rehazentrum Valens, Valens, Switzerland
[4] Kliniken Valens Rehazentrum Valens, Klin Muskuloskelettale & Internist Rehabil, Taminapl 1, CH-7317 Valens, Switzerland
[5] Univ Bern, Univ Hosp Bern, Dept Geriatr, Inselspital,Fac Med, Bern, Switzerland
关键词
Sars-CoV-2; Covid-19; rehabilitation; therapy; outcomes; COHORT;
D O I
10.1055/a-1729-7706
中图分类号
R49 [康复医学];
学科分类号
100215 ;
摘要
Objective Does the rehab process of acutely ill Covid-19 patients differ from recovered Covid-19 patients and other rehab patients? Comparison of the reha-course between acutely ill Covid-19 patients, recovered patients and rehab patients without Covid-19. Design: case-control study. Material and Methods Patients assigned to rehab in the period from 01.04 to 30.06.2020 with active Covid-19 disease (IG), recovered Covid-19 patients (PCG) and simultaneously rehabilitated persons matched by age, gender and comorbidity (Ko) were included. The primary endpoint was ADL- independence (FIM), secondary endpoints were quality of life (EQ5D-VAS), physical and mental health (PROMIS10) and mobility (TUG and 6MWT). Results 101 patients were included: IG=15; PCG=22; Ko=64. At entry, ADL-independence and quality of life were significantly highest in the IG (FIM IG 95.3 vs. PCG 78.3, vs. Ko 79.6; ANOVA p=0.029; EQ5D-VAS IG 56.1 vs. PCG 36.6 vs. Ko 51.0; ANOVA p=0.010). There were no differences in PROMIS10 and mobility. All three groups improved significantly from entry to discharge. The IG performed best in the FIM (IG 109.7 vs. PCG 97.2 vs. Ko 93.6; ANOVA p=0.039). The control group achieved the worst results with regard to mobility at discharge (TUG Ko 19.3 sec vs. 9.6 sec IG and 8.3 sec PCG). In the 6MWT, the PCG showed the best result (471 m vs. IG 416 m and Ko 389 m; difference n.s.). Conclusion All three patient groups benefited well from the rehab program. In addition, rehab measures bring a benefit also for isolated Covid-19 patients. In particular, recovered Covid-19 patients benefit greatly from the rehab program.
引用
收藏
页码:17 / 27
页数:11
相关论文
共 50 条
  • [31] PNEUMOMEDIASTINUM AND PNEUMOTHORAX IN COVID-19 PNEUMONIA: A MATCHED CASE-CONTROL STUDY
    Devarajan, Anusha
    Tekin, Aysun
    Sakata, Kenneth K.
    Cartin-Ceba, Rodrigo
    Sharma, Mayank
    Qamar, Shahraz
    Morales, Diana J. Valencia
    Welle, Stephanie
    Sharma, Nikhil
    Taji, Jamil
    Khosa, Sandeep
    Lal, Amos
    Brown, Meghan L.
    Talaei, Fahimeh
    Domecq, Juan Pablo
    Azadeh, Natalya
    CHEST, 2022, 162 (04) : 1383A - 1384A
  • [32] The Risk Factors for the Exacerbation of COVID-19 Disease: A Case-control Study
    Fan, Ying
    Wang, Xuefei
    Jun Zhang
    Mo, Daorong
    Xiao, Xuexia
    JOURNAL OF CLINICAL NURSING, 2021, 30 (5-6) : 725 - 731
  • [33] Severe COVID-19 in the context of a vaccinated population: Case-control study
    Diaz-Munoz, Irving
    Medina-Gomez, Oswaldo Sinoe
    Julian-Bello, Gonzalo Ivan
    REVISTA DE EPIDEMIOLOGIA E CONTROLE DE INFECCAO, 2024, 14 (01): : 66 - 74
  • [34] Severely low testosterone in men with COVID-19: A case-control study
    Capogrosso, P.
    Pontillo, M.
    Gregori, S.
    Tassara, M.
    Boeri, L.
    Carenzi, C.
    Abbate, C.
    Cignoli, D.
    Ferrara, A. M.
    Cazzaniga, W.
    Landoni, G.
    Querini, Rovere P.
    Ciceri, F.
    Montorsi, F.
    Salonia, A.
    EUROPEAN UROLOGY, 2021, 79 : S725 - S726
  • [35] Covid-19 infection in pregnant women in Dubai: a case-control study
    Komal Sundeep Hazari
    Rasha Abdeldayem
    Litty Paulose
    Nimmi Kurien
    Zukaa Almahloul
    Hozaifah Mohammad
    Taghrid Faek A. Elgergawi
    Maryam Alkhanbouli
    Khalid Mahmoud
    Atif Bashir Fazari
    Amar Hassan
    Riad Bayoumi
    BMC Pregnancy and Childbirth, 21
  • [36] Xuebijing injection in the treatment of COVID-19: a retrospective case-control study
    Guo, Hu
    Zheng, Jiangyuan
    Huang, Gu
    Xiang, Yi
    Lang, Chunhui
    Li, Boqun
    Huang, Daoqiu
    Sun, Qiuyan
    Luo, Yaling
    Zhang, Yulian
    Huang, Liang
    Fang, Wei
    Zheng, Yu
    Wan, Suxin
    ANNALS OF PALLIATIVE MEDICINE, 2020, 9 (05) : 3235 - 3248
  • [37] Severely low testosterone in males with COVID-19: A case-control study
    Salonia, Andrea
    Pontillo, Marina
    Capogrosso, Paolo
    Gregori, Silvia
    Tassara, Michela
    Boeri, Luca
    Carenzi, Cristina
    Abbate, Costantino
    Cignoli, Daniele
    Ferrara, Anna Maria
    Cazzaniga, Walter
    Rowe, Isaline
    Ramirez, Giuseppe A.
    Tresoldi, Cristina
    Mushtaq, Junaid
    Locatelli, Massimo
    Santoleri, Luca
    Castagna, Antonella
    Zangrillo, Alberto
    De Cobelli, Francesco
    Tresoldi, Moreno
    Landoni, Giovanni
    Rovere-Querini, Patrizia
    Ciceri, Fabio
    Montorsi, Francesco
    ANDROLOGY, 2021, 9 (04) : 1043 - 1052
  • [38] Determinants of COVID-19 severity in Ethiopia: a multicentre case-control study
    Tadie, Manayesh Bantie
    Yimer, Yimer Seid
    Taye, Girma
    BMJ OPEN, 2024, 14 (05): : 1 - 7
  • [39] Effect of HIV Status and Charlson Comorbidity Index on COVID-19 Clinical Outcomes in a Case-Control Study
    Gerrity, Rebecca C.
    Parkinson, Melissa
    Strength, Rachel
    Animalu, Chinelo N.
    Davidson, Nathan
    Fuchs, Christian J.
    Jackson, Christopher D.
    Summers, Nathan A.
    SOUTHERN MEDICAL JOURNAL, 2024, 117 (11) : 651 - 656
  • [40] Diabetic emergencies during the COVID-19 pandemic: A case-control study
    Huda, M. S. B.
    Shaho, S.
    Trivedi, B.
    Fraterrigo, G.
    Chandrarajan, L.
    Zolfaghari, P.
    Dovey, T. M.
    Garrett, C. G.
    Chowdhury, T. A.
    DIABETIC MEDICINE, 2021, 38 (01)